Language NL EN DE ES FR UK IT

Rebuild analysis

Kartel Analysis

Clean base for MEP, document and thematic network analysis. No hard political labels, but auditable evidence.

You are here

Reform Agendas and compatibility with ‘do no significant harm’ principle

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

Reform Agendas and compatibility with ‘do no significant harm’ principle

Schriftelijke vraag | 2025-02-10 | source: parliamentary_questions

Open bronpagina Leesbare metadata Wikipedia zoeken

4Actors
0Signals
10EP term

Actors

Gordan Bosanac

Role: co-author
Method: name-normalized | confidence 0.7500

Lena Schilling

Role: co-author
Method: name-normalized | confidence 0.7500

Thomas Waitz

Role: co-author
Method: name-normalized | confidence 0.7500
Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

Reform Agendas and compatibility with ‘do no significant harm’ principle

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer parliamentary_questions
Canonical identifier E-10-2025-000599
Official source URL https://data.europarl.europa.eu/eli/dl/doc/E-10-2025-000599
Title and language layer English primary, Dutch fallback
EP term 10

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: 2025-02-10
Keywords: Reform Agendas and compatibility with ‘do no significant harm’ principle
Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News
Supporting layers Signals

Signals

No signal clusters found for this topic yet.
Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard